News & Publications

Oct 25

Stemina to Present a Poster at American College of Toxicology Annual Meeting

Oct 25, 2017
Jessica Palmer, Stemina’s Associate Director of Toxicology, will present a poster at the American College of Toxicology’s 38th Annual Meeting, held November 5-8, 2017 in Palm Springs, California. Anyone interested in cardiotoxicity assays is encouraged to attend. Development of a Targeted Biomarker Assay to Predict Cardiotoxicity Potential Using Metabolomics and Human Induced Stem Cell-Derived Cardiomyocytes

Read more
Sep 27

Stemina Featured as an Innovative Madison-Area Business

Sep 27, 2017
In collaboration with the Greater Madison Chamber of Commerce, the Wisconsin State Journal produced a special section to “highlight and explore innovation efforts.” Each company’s profile is written by its leader. Stemina’s CEO, Elizabeth Donley, penned our article and also graces the cover of the section. Read Stemina’s profile Explore other companies in the section

Read more
Aug 25

Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, PhD, Former Head of Roche Molecular Diagnostics

Aug 25, 2017
Dr. Driesmann, a leader in the diagnostics industry, will guide Stemina’s commercialization strategy. Read the full press release.

Read more
Jun 14

Stemina’s Jessica Palmer to Present at Teratology Society Annual Meeting

Jun 14, 2017
Jessica Palmer, Stemina’s Associate Director of Toxicology, will present at the Teratology Society’s 57th Annual Meeting, held June 24-28, 2017 in Denver. Anyone interested in developmental toxicity assays is encouraged to attend. Prediction of Developmental Toxicity Potential by In Vivo Exposures with a Biomarker-Based Human Pluripotent Stem Cell Assay This presentation is part of Platform

Read more
Feb 20

Stemina to Present Sponsored Session, Poster at SOT’s Annual Meeting & ToxExpo 2017

Feb 20, 2017
Stemina Biomarker Discovery will be well represented at the Society of Toxicology’s 56th Annual Meeting and ToxExpo. In addition to participating in SOT as an exhibitor (booth 2506), Stemina’s Jessica Palmer, Associate Director of Toxicology, will present new research in two sessions: Poster session: Monday, March 13th | 9:30 AM – 12:45 PM | P331

Read more
Feb 9

NeuroPointDX Partners with Ovid Therapeutics to Identify Biomarkers for Angelman Syndrome

Feb 9, 2017
Together, Ovid and NeuroPointDX will use metabolomics data to better understand the rare neuro-genetic disorder known as Angelman Syndrome. NeuroPointDX’s metabolomics technology will be used in Ovid’s phase 2 STARS trial of its drug candidate, OV101.

Read more
Oct 14

Stemina Presenting Poster at ACT 37th Annual Meeting, November 6–9, 2016

Oct 14, 2016
Jessica Palmer will present a poster entitled “Human Pluripotent Stem Cell-Based Assay Predicts Developmental Toxicity Potential of ToxCast Chemicals” at the annual meeting of the American College of Toxicology in Baltimore. Poster Abstract: Worldwide initiatives to screen for toxicity potential among the thousands of chemicals currently in use require inexpensive and high-throughput in vitro models to

Read more
Oct 14

Stemina to Present at Use of Cardiomyocytes for the Assessment of Proarrhythmic Risk Conference October 25-26

Oct 14, 2016
Jessica Palmer will present a poster entitled “Development of a Biomarker-Based Cardiotoxicity Assay using Human Pluripotent Stem Cell-Derived Cardiomyocytes” at the upcoming Use of Cardiomyocytes for the Assessment of Proarrhythmic Risk Conference in Arlington, Virginia.  Poster Abstract: Cardiac safety is one of the leading causes of late-stage compound attrition in the pharmaceutical industry and accounts for 28% of

Read more
Sep 27

Stemina CEO Beth Donley to deliver welcome remarks at 64th Annual Chamber Dinner

Sep 27, 2016
Stemina’s CEO, Beth Donley, will deliver the welcome remarks at the 64th Annual Greater Madison Chamber of Commerce Dinner to be held September 28, 2016 at the Monona Terrace. Ms. Donley currently serves as the Board Chair. For more information, follow the link below: Read More  

Read more
Jun 3

Stemina receives exceptional rating from EPA on devTOX assay performance

Jun 3, 2016
Stemina is proud to announce that it has received an exceptional rating from the US Environmental Protection Agency for its work under ToxCast.  Stemina’s devTOX assay is the only human developmental toxicity assay.  Stemina offers its stem cell based assay in both human embryonic and induced pluripotent cell culture formats. Excerpt from the Contractor Performance

Read more
May 13

Stemina to Present Poster at IMFAR 2016

May 13, 2016
The International Meeting for Autism Research (IMFAR) will be held in Baltimore, Maryland May 11-14. Visit the Saturday morning poster session to view our poster, “Evidence for Metabolomic Phenotypes Based on Analysis of Plasma from the APP Cohort.”

Read more
Mar 31

US EPA Presents devTOXqp Data

Mar 31, 2016
Thomas Knudsen of the US EPA presented data on Stemina’s devTOXqp assay at the 2016 Society of Toxicology annual meeting.

Read more
Mar 1

Visit Stemina at SOT’s ToxExpo 2016

Mar 1, 2016
Stemina will sponsor a session at the 2016 SOT Annual Meeting titled “Practical Application of a Human Stem Cell Assay for Developmental Toxicity Testing.” The session is Tuesday from 3:00 to 4:00 in Room 211. Stemina’s poster titled “Combination of a Human Pluripotent Stem Cell and Zebrafish Assay to Predict the Developmental Toxicity of Chemicals”

Read more
Feb 26

Autism Blood Test on Horizon

Feb 26, 2016
A University of Wisconsin—Madison spinoff is screening blood samples in an effort to develop a biologically based method to diagnose autism through its diagnostic biomarker division, NeuroPointDX.

Read more
Feb 18

Donley Named InBusiness Exec of the Year

Feb 18, 2016
Stemina’s CEO, Beth Donley, is named Executive of the Year by Madison’s InBusiness Magazine.

Read more